Level of specific immunoglobulin to hepatitis B virus core antigen in groups of health care workers with different risk of parenteral viral hepatitis B infection

https://doi.org/10.34215/1609-1175-2025-1-51-58
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
Objective. To determine the incidence of anti-HBc in groups of health care workers with different risk of occupational parenteral viral hepatitis B (VHB) infection previously vaccinated against hepatitis B.
Materials and methods. The total sample of 1643 people was divided into cohorts of people with high risk of occupational infection, 976 people (58.9%), and with low risk of parenteral infection, 676 people (41.1%). The immunofluorescence assay was used for anti-HBs and anti-HBc.
Results. The share of anti-HBc positive and anti-HBc negative individuals is almost the same in both groups. Statistical calculations show that the relationship between the presence and absence of anti-HBc and the levels of humoral immunity in both groups is statistically significant (p < 0.001). Anti-HBc in the serum of the vaccinated people is detected 2.7 times less incident compared to the unvaccinated.
Conclusion. No significant difference in the detection of anti-HBc in the groups of health workers at high and low risk of parenteral infection was revealed. A statistically significant correlation was found between the level of postvaccinal immunity in vaccinated persons and the presence of anti-HBc. Immunization against VHB prevents not only its acute form, but also sterile, chronic, or latent ones.
About the Authors
I. A. KhrapunovaRussian Federation
Isabella A. Khrapunova, Dr. Sci. (Med.), Professor of the Department of Epidemiology and Modern Vaccination Technologies of the Institute of Professional Education,
Leading Researcher of the Laboratory for the Prevention of Infections Associated with the Provision of Medical,
5A Maly Kazenniy Lane, Moscow, 105064
M. P. Kostinov
Russian Federation
Moscow
N. A. Magomedova
Russian Federation
Moscow;
Makhachkala
A. V. Link
Russian Federation
Moscow
M. N. Loktionov
Russian Federation
Moscow
M. A. Cherdantsev
Russian Federation
Ulyanovsk
A. A. Krupina
Russian Federation
Ulyanovsk
A. A. Poddubikov
Russian Federation
Ulyanovsk
References
1. Methodological guidelines 3.1. Prevention of infectious diseases. Epidemiological surveillance of hepatitis B - MU 3.1.2792-10 (In Russ.).
2. Danilova ES. Nosocomial infections among medical professionals of therapeautic-and-prophylactic organizations. I. P. Pavlov Russian Medical Biological Herald. 2013;21(1):137-144 (In Russ.).
3. Filatov NN, Hrapunova IA, Filippov VYu. Main factors of occupational contamination of health care workers with hemocontact infections. Epidemiology and Vaccinal Prevention. 2005;2(21):41-45 (In Russ.).
4. Isaeva OV, Il'chenko LYu, Kozhanova TV, Klushkina VV, Saryglar AA, Al'-Sharabi Shukri, Amon EP, Kyuregyan KK, Mihajlov MI. The impact of universal vaccination against hepatitis b on the prevalence of hepatitis d in endemic region. Infection Diseases: News, Opinions, Training. 2019;2(29):36-42 (In Russ.). https://doi.org/10.24411/2305-3496-2019-12004
5. Krarup HB, Rex KF, Andersen S. Risk of hepatitis B when migrating from low to high endemic areas. International Journal of Circumpolar Health. 2020;79(1):1817274. https://doi.org/10.1080/2242 3982.2020.1817274
6. Nikitina GYu, Semenenko TA, Gotvyanskaya TP, Hahaeva IB, Konopleva MV, Nikolaeva OG, Yarosh LV, Kozhevnikova LK, Suslov AP. The prevalence of parenteral hepatitis markers among the medical personnel in the Russian Federation regions with different intensity of epidemic process. Clinical Microbiology and Antimicrobial Chemotherapy. 2017;19(2):161-167 (In Russ.).
7. Bazhenov AI, Elgort DA, Feldsherova AA, Budnitskaya PZ, Nikitina GI, Hats YuS, Konopleva MV, Godkov MA, Borisova VN, Semenenko TA, Suslov AP. The comparative estimation of anti-hbs activity against native and recombinant type antiHBs. Epidemiology and Vaccinal Prevention. 2012;2(63):76-81 (In Russ.).
8. Batskikh SN. Resolved hepatitis b: achieved or imaginary wellbeing? Russian Journal of Gastroenterology, Hepatology, Coloproctology, 2021;31(1):7-19 (In Russ.). https://doi.org/ 10.22416/1382-4376-2021-31-1-7-19
9. Lok AS, Everhart JE, Di Bisceglie AM, Kim HY, Hussain M, Morgan TR; HALT-C. Trial Group Occult and previous hepatitis b virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. Hepatology. 2011;54(2):434-42. https://doi.org/10.1002/hep.24257
10. Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560-1599. https://doi.org/10.1002/hep.29800
11. Grjibovski AM, Ivanov SV, Gorbatova MA. Analysis of nominal and ordinal data using statistica and spss software. Science & Healthcare, 2016;6:5-39 (In Russ.).
12. Tkachenko NE, Yasakov DS, Fisenko AP, Makarova SG. Actual problems of hepatitis B vaccine prophylaxis. Russian Pediatric Journal. 2020; 23(5): 313-317. https://doi.org/10.18821/1560-9561-2020-23-5-313-317
13. Kostinov MP. Adult vaccination: from strategy to tactics - a guide for doctors. M.: Gruppa MDV, 2020 (In Russ.).
14. Ovchinnikova OV, Sirotinskaya EK Prevalence of markers of viral hepatitis B and C among medical personnel of a multidisciplinary medical institution. Zdorov'e. Medicinskaja jekologija. Nauka. 2015; 2(60): 78-82. URL: https://yadi.sk/i/ucVnFPusfPs6f
15. Shrestha SK, Bhattarai MD. The study of hepatitis B among various categories of medical workers. J Coll Physicians Surg Pak. 2006 February; 16(2):108-11. PMID: 16499802.
Review
For citations:
Khrapunova I.A., Kostinov M.P., Magomedova N.A., Link A.V., Loktionov M.N., Cherdantsev M.A., Krupina A.A., Poddubikov A.A. Level of specific immunoglobulin to hepatitis B virus core antigen in groups of health care workers with different risk of parenteral viral hepatitis B infection. Pacific Medical Journal. 2025;(1):51-58. (In Russ.) https://doi.org/10.34215/1609-1175-2025-1-51-58